Top Story

Cimzia labeling change addresses concerns for use during pregnancy

March 22, 2018
FDA News

FDA approves Ilumya for moderate-to-severe plaque psoriasis

March 21, 2018
Today, Sun Pharma announced that Ilumya has been approved by the FDA for the treatment of moderate-to-severe plaque psoriasis in adults who are eligible for systemic…
In the Journals

Biologic use before, during pregnancy not linked to preterm birth

March 15, 2018
The use of biologic medications for autoimmune diseases prior to or during pregnancy is not associated with an increased risk for preterm delivery or infants that are…
In the JournalsPerspective

Biosimilar competition in U.S. limited by accumulative regulatory failures

March 8, 2018
Despite the expedited pathway for biosimilars enacted by the Biologics Price Competition and Innovation Act of 2009, the development of competition in the U.S. biologics…
More Headlines »